ADAMIS ANTHONY P 4
4 · EyePoint Pharmaceuticals, Inc. · Filed Jun 27, 2022
Insider Transaction Report
Form 4
ADAMIS ANTHONY P
Director
Transactions
- Award
Restricted Stock Units
2022-06-23+6,000→ 6,000 totalExercise: $0.00→ Common Stock (6,000 underlying) - Award
Stock Option (Right to Buy)
2022-06-23+22,000→ 22,000 totalExercise: $7.54Exp: 2032-06-23→ Common Stock (22,000 underlying)
Footnotes (2)
- [F1]The restricted stock units will vest in three equal annual installments beginning June 23, 2023.
- [F2]The option becomes exercisable in three ratable annual installments beginning on June 23, 2023.